RRAGA

Chr 9

Ras related GTP binding A

Also known as: FIP-1, FIP1, RAGA

The protein is a guanine nucleotide-binding protein that regulates mTORC1 signaling in response to amino acid availability by forming heterodimeric complexes at the lysosome and recruiting mTORC1 for activation. Mutations in this gene cause autosomal recessive epileptic encephalopathy and neurodevelopmental disorders with early infantile onset. The gene shows moderate constraint to loss-of-function variants, and affected children typically present with seizures, developmental delays, and neurological regression in the first months of life.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.71
Clinical SummaryRRAGA
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.23) despite low pLI — interpret in context.
📋
ClinVar Variants
21 unique Pathogenic / Likely Pathogenic of 21 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.71LOEUF
pLI 0.356
Z-score 2.13
OE 0.23 (0.090.71)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
2.99Z-score
OE missense 0.36 (0.290.45)
63 obs / 173.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.23 (0.090.71)
00.351.4
Missense OE0.36 (0.290.45)
00.61.4
Synonymous OE1.27
01.21.6
LoF obs/exp: 2 / 8.8Missense obs/exp: 63 / 173.7Syn Z: -1.75
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongRRAGA-related cataractOTHERAD
DN
0.6744th %ile
GOF
0.6345th %ile
LOF
0.4234th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

21 submitted variants in ClinVar

Classification Summary

Pathogenic21
21
Pathogenic

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
21
Likely Pathogenic
0
VUS
0
Likely Benign
0
Benign
0
Total21

Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RRAGA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC